Healthcare: 44 NSE stocks
Data dated 6 Nov 2026 (NSE close) · refreshed every trading day
The Healthcare group has 44 stocks in our NSE end-of-day data, using the industry label NSE assigns to each listed company. On 6 Nov 2026, 28 of them closed higher and 15 closed lower, and the equal-weight average member moved +0.3% on the day. Equal-weight means every stock counts the same, so a small company moves the average as much as the largest one.
Over the last 20 sessions, from the close of 8 Oct 2026 to 6 Nov 2026, the group's equal-weight return was +6.4%, which ranks it 5 of 19 NSE industry groups on 20-session return. Measured against the NIFTY 50 from 8 Oct 2026 to 6 Nov 2026 (the latest index file in the data), the group returned +6.4% against the index's +10.4%, which is 4.0 pp behind the benchmark.
93% of members closed above their own 20-session average price, against 70% for all stocks in our data. That is a simple breadth reading: it says how many members are trading above their recent average, not whether the group will keep moving.
Within the group, the largest 20-session gains were ACUTAAS (+23.9%), PPLPHARMA (+21.8%), SYNGENE (+20.6%), and the largest declines were CAPLIPOINT (−6.5%), NEULANDLAB (−6.3%), WOCKPHARMA (−4.1%). The spread between them is a reminder that a group average can hide very different stories.
On delivery, the average member's delivery % was 0.95× its own 20-session median today, with 1 delivery spike(s) (at least 1.3× normal delivery on 1.5× volume) and 2 churn day(s) (heavy volume, under 30% delivery).
1 member(s) had a one-day move larger than ±20% in the last 20 sessions, which in raw exchange prices usually means a split or bonus; they are listed but left out of the averages.
Figures are computed automatically from exchange data after the close and refresh every trading day. They describe the group; they are not a recommendation.
Members
| Stock | Close | Day | 20 sessions | Delivery | vs own median | Footprint today |
|---|---|---|---|---|---|---|
| ACUTAAS Acutaas Chemicals | 3,786.60 | ▲ up +0.4% | ▲ up +23.9% | 44% | 0.9× | none |
| PPLPHARMA Piramal Pharma | 239.32 | ▲ up +0.3% | ▲ up +21.8% | 39% | 1.0× | none |
| SYNGENE Syngene International | 417.30 | ▲ up +0.8% | ▲ up +20.6% | 70% | 1.4× | none |
| EMCURE Emcure Pharmaceuticals | 2,212.80 | ▼ down −1.4% | ▲ up +19.5% | 62% | 1.2× | none |
| SAILIFE Sai Life Sciences | 1,785.10 | ▲ up +11.9% | ▲ up +18.6% | 13% | 0.2× | heavy volume, low delivery |
| GLENMARK Glenmark Pharmaceuticals | 2,590.00 | ▲ up +4.4% | ▲ up +18.1% | 21% | 0.4× | heavy volume, low delivery |
| LAURUSLABS Laurus Labs | 2,340.00 | ▼ down −0.3% | ▲ up +17.1% | 53% | 1.2× | none |
| DRREDDY Dr. Reddy's Laboratories | 1,373.00 | ▲ up +0.5% | ▲ up +16.4% | 54% | 1.0× | none |
| NH Narayana Hrudayalaya | 1,903.00 | ▼ down −0.7% | ▲ up +12.3% | 59% | 1.1× | none |
| DIVISLAB Divi's Laboratories | 10,320.50 | ▲ up +1.8% | ▲ up +10.3% | 57% | 0.9× | none |
| APOLLOHOSP Apollo Hospitals Enterprise | 8,446.00 | ▲ up +0.9% | ▲ up +10.2% | 54% | 0.9× | none |
| AUROPHARMA Aurobindo Pharma | 1,800.00 | ▲ up +0.8% | ▲ up +9.4% | 46% | 0.9× | none |
| MEDANTA Global Health | 1,387.60 | ▼ down −0.1% | ▲ up +8.7% | 49% | 1.0× | none |
| ONESOURCE Onesource Specialty Pharma | 1,599.80 | ▲ up +1.1% | ▲ up +8.2% | 42% | 0.8× | none |
| RUBICON Rubicon Research | 1,659.30 | ▼ down −4.7% | ▲ up +8.1% | 47% | 0.9× | none |
| CIPLA Cipla | 1,411.00 | ▲ up +0.5% | ▲ up +8.0% | 62% | 1.0× | none |
| ZYDUSLIFE Zydus Lifesciences | 1,197.90 | ▲ up +0.4% | ▲ up +7.7% | 47% | 0.9× | none |
| MAXHEALTH Max Healthcare Institute | 934.00 | ▲ up +0.2% | ▲ up +6.9% | 56% | 1.0× | none |
| MANKIND Mankind Pharma | 2,540.00 | ▲ up +0.9% | ▲ up +6.7% | 51% | 0.9× | none |
| SUNPHARMA Sun Pharmaceutical Industries | 1,860.00 | ▲ up +1.7% | ▲ up +5.7% | 59% | 1.0× | none |
| ASTERDM Aster DM Quality Care | 713.15 | ▼ down −0.9% | ▲ up +5.3% | 61% | 1.1× | 3+ days above-normal delivery |
| KIMS Krishna Institute of Medical Sciences | 723.00 | ▼ down −1.1% | ▲ up +5.2% | 85% | 1.6× | delivery spike, down candle |
| ANTHEM Anthem Biosciences | 915.55 | ▲ up +0.2% | ▲ up +4.9% | 59% | 1.1× | none |
| BIOCON Biocon | 365.10 | ▲ up +0.9% | ▲ up +4.3% | 53% | 1.1× | none |
| LALPATHLAB Dr. Lal Path Labs | 1,970.00 | ▲ up +0.2% | ▲ up +3.7% | 61% | 1.0× | none |
| ABBOTINDIA Abbott India | 26,345.00 | ▼ down −1.0% | ▲ up +3.0% | 47% | 0.9× | none |
| GLAND Gland Pharma | 3,169.30 | ▲ up +0.8% | ▲ up +2.9% | 58% | 1.0× | none |
| TORNTPHARM Torrent Pharmaceuticals | 4,750.00 | ▲ up +0.9% | ▲ up +2.9% | 52% | 0.8× | none |
| LUPIN Lupin | 1,988.10 | flat 0.0% | ▲ up +2.6% | 47% | 0.8× | none |
| VIJAYA Vijaya Diagnostic Centre | 1,468.60 | ▲ up +2.1% | ▲ up +2.6% | 30% | 0.6× | none |
| NATCOPHARM NATCO Pharma | 807.00 | ▲ up +1.3% | ▲ up +1.5% | 38% | 0.7× | none |
| RAINBOW Rainbow Childrens Medicare | 1,244.40 | ▼ down −1.4% | ▲ up +1.1% | 47% | 0.9× | none |
| ALKEM Alkem Laboratories | 5,297.00 | ▲ up +2.1% | ▲ up +0.9% | 41% | 0.7× | none |
| FORTIS Fortis Healthcare | 766.90 | ▼ down −6.5% | ▲ up +0.5% | 45% | 0.8× | none |
| POLYMED Poly Medicure | 1,612.30 | ▲ up +0.6% | ▲ up +0.4% | 47% | 0.9× | none |
| IPCALAB Ipca Laboratories | 1,941.80 | ▼ down −0.4% | ▲ up +0.2% | 51% | 1.0× | none |
| GLAXO Glaxosmithkline Pharmaceuticals | 2,524.80 | ▲ up +1.0% | ▼ down −0.4% | 68% | 1.3× | delivery spike, green candle; 3+ days above-normal delivery |
| GRANULES Granules India | 799.65 | ▲ up +0.7% | ▼ down −1.9% | 43% | 0.9× | none |
| COHANCE Cohance Lifesciences | 433.55 | ▼ down −3.4% | ▼ down −2.0% | 37% | 0.8× | none |
| AJANTPHARM Ajanta Pharmaceuticals | 3,307.70 | ▲ up +0.8% | ▼ down −3.7% | 59% | 1.1× | none |
| WOCKPHARMA Wockhardt | 1,947.00 | ▼ down −2.1% | ▼ down −4.1% | 38% | 0.9× | none |
| NEULANDLAB Neuland Laboratories | 19,700.00 | ▼ down −0.4% | ▼ down −6.3% | 55% | 1.2× | none |
| CAPLIPOINT Caplin Point Laboratories | 2,382.50 | ▼ down −1.6% | ▼ down −6.5% | 48% | 1.0× | none |
| CONCORDBIO Concord Biotech | 632.60 | ▼ down −6.0% | excluded* | 36% | 0.8× | none |
Sorted by 20-session return. "vs own median" = today's delivery % ÷ the stock's median of the previous 20 sessions. Footprint labels come from our footprint engine and describe today's data only. * One-day move larger than ±20% in the last 20 sessions (probable split or bonus in raw prices): excluded from averages.
Source: NSE bhavcopy (prices, volume, delivery), NSE provisional FII/DII cash data and NSE F&O bhavcopy, via the tietiy data store (TDT). Benchmark: NIFTY 50, 8 Oct 2026 to 6 Nov 2026. Descriptive context, not investment advice.